​

Funding Round

Series E - MeMed

Series E - MeMed

Investment Firm

Overview

MeMed Diagnostics is a personalized diagnostics company, focused on preventing antibiotics misuse.

Announced Date

Jan 10, 2022

Funding Type

Series E

Highlights

Location

Asia

Social

Investor Lead

Horizons Ventures

Horizons Ventures

Horizons Ventures is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

9

Investor Name
Participant InvestorPoalim Equity
Participant InvestorPhoenix Insurance
Participant InvestorHorizons Ventures
Participant InvestorWestern Technology Investment
Participant InvestorSocial Capital

Round Details and Background

MeMed raised $93000000 on 2022-01-10 in Series E

MeMed Diagnostics is a personalized diagnostics company, focused on preventing antibiotics misuse.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 10, 2022
Series E - MeMed
11-93.0M
Aug 26, 2013
Series B - MeMed
1-undefined
Jul 06, 2015
Series C - MeMed
2-undefined
Sep 15, 2011
Series A - MeMed
1-undefined

Recent Activity

There is no recent news or activity for this profile.